Arena Pharmaceuticals
$51.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$51.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.09 (-2.08%) Today
$0.00 (0.00%) As of 5:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ARNA and other stocks, options, ETFs, and crypto commission-free!
About ARNA
Arena Pharmaceuticals, Inc. Common Stock, also called Arena Pharmaceuticals, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. Read More It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.
Employees
194
Headquarters
San Diego, California
Founded
1997
Market Cap
2.60B
Price-Earnings Ratio
4.54
Dividend Yield
0.00
Average Volume
380.69K
High Today
$52.63
Low Today
$50.87
Open Price
$52.18
Volume
468.33K
52 Week High
$64.48
52 Week Low
$31.97
Collections
Price Paid on Robinhood
42% Higher
Right Now
52 Week Low
$31.97
Average Price Paid
$36.01
52 Week High
$51.63
Analyst Ratings
89%
of 9 ratings
Buy
89%
Hold
11%
Sell
0%
ARNA Earnings
-$1.24
$3.80
$8.85
$13.89
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, After Hours